Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Carlos V. Payá, Atul Humar, Ed Dominguez et al. · American Journal of Transplantation · 2004 · 884 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Anders Åsberg, Atul Humar, Halvor Rollag et al. · American Journal of Transplantation · 2007 · 425 citations

Pharmacy, Microbiology, Pharmacotherapy +16

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Supha K. Arthurs, A.J. Eid, Rachel Pedersen et al. · Clinical Infectious Diseases · 2008 · 272 citations

Medicine, Infectious Diseases, Nephrology +17

CLINICAL UTILITY OF QUANTITATIVE CYTOMEGALOVIRUS VIRAL LOAD DETERMINATION FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1

Atul Humar, Daniel B. Gregson, Angela M. Caliendo et al. · Transplantation · 1999 · 223 citations · Full text

Veterinary Medicine, Clinical Sciences, Infectious Diseases +14

Cytomegalovirus (CMV) DNA Load Predicts Relapsing CMV Infection after Solid Organ Transplantation

Irene G. Sia, Jennie Wilson, Cynthia Groettum et al. · The Journal of Infectious Diseases · 2000 · 222 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13